一种联合疫苗策略,可诱导针对阿雷科林的保护性免疫力
Xu-Guang Yin1, Xiang-Zhao Chen2, Jia-Ling Qiu1
1Center for Drug Delivery System Research, School of Medicine, Shaoxing University, 900 Chengnan Avenue, Shaoxing, Zhejiang, 312000, China.
European journal of medicinal chemistry
|March 2, 2024
概括
开发一种阿雷科林疫苗可以对抗白中毒,这是导致口腔癌的主要原因. 针对阿里科林的新型哈普顿设计显示出创造有效的针对贝特尔坚果滥用的疫苗的希望.
科学领域:
- 成研究研究成研究
- 疫苗的研发工作正在进行中.
- 口腔癌的预防口腔癌的预防
背景情况:
- 贝特利的是导致口腔下纤维化和口腔癌的首要原因,造成了重大的社会经济负担.
- 疫苗接种是一个潜在的策略,可以缓解贝特尔滥用和管理意外过量.
研究的目的:
- 为了合成新的基于阿雷科林的哈普,用于阿雷科林疫苗开发.
- 为了评估不同的哈普顿设计在产生高亲缘关系抗体对阿雷科林的有效性.
主要方法:
- 合成了两种基于阿雷科林的新型 hapten.
- 哈普与牛血清白蛋白 (BSA) 的结合,产生免疫原体.
- 免疫接种和抗体亲和度评估.
主要成果:
- 生成的抗体对阿雷科林具有很高的亲和力,对瓜科林的结合性降低,对阿雷卡丁或瓜没有亲和力.
- 与Arec-CONH-BSA相比,使用Arec-N-BSA (N位置结合) 接种疫苗导致抗体亲和力更高.
- 在接种疫苗的受试者中,阿雷科林诱导的止痛和低温分别减弱和减弱.
结论:
- 基于阿雷科林的新型哈普可以引起对阿雷科林疫苗开发至关重要的高 afinity 抗体.
- 阿雷克-N-BSA结合物是一种有前途的免疫原,可产生针对阿雷科林的有效抗体.
- 阿雷科林疫苗有潜力减轻阿雷科林的生理影响,为成治疗提供了一条新的途径.
更多相关视频
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
5.0K
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
3.4K
相关概念视频
Vaccinations
44.5K
Overview
44.5K
Cross-reactivity
31.1K
Overview
31.1K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Active versus Passive Immunity
642
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
642
